Immune checkpoint inhibitors in prostate cancer: Current and future practice
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts consider the current role of immune checkpoint inhibitors in prostate cancer and possible future directions.
The experts
Prof. Karim Fizazi - Gustave Roussy, Villejuif, France
Dr Sandy Srinivas - Stanford University, Stanford, CA, USA
Prof. Johann de Bono - The Institute of Cancer Research, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck Sharp & Dohme Corp. This activity is jointly provided by USF Health and touchIME.
For further information…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.